DrugPatentWatch Database Preview

Iohexol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for iohexol and what is the scope of iohexol freedom to operate?

Iohexol is the generic ingredient in ten branded drugs marketed by Interpharma Praha As and Ge Healthcare, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for iohexol. Three suppliers are listed for this compound.

Summary for iohexol

US Patents:	0
Tradenames:	10
Applicants:	2
NDAs:	3
Drug Master File Entries:	3
Suppliers / Packagers:	3
Bulk Api Vendors:	69
Clinical Trials:	43
Patent Applications:	2,413
Formulation / Manufacturing:	see details
DailyMed Link:	iohexol at DailyMed

Pharmacology for iohexol

Drug Class	Radiographic Contrast Agent
Mechanism of Action	X-Ray Contrast Activity

Medical Subject Heading (MeSH) Categories for iohexol

Contrast Media

Synonyms for iohexol

1-N,3-N-bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide

1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-

1,3-benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-

1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-

108I950

4419T9MX03

5-(N-2-3-DIHYDROXYPROPYL-ACETMIDO)-2,4,6-TRIIODO-N,N'-bis-(2,3-DIHYDROXYPROPYL)-ISOPHTHALAMIDE

5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,N inverted exclamation marka-bis(2,3-dihydroxypropyl)isophthalamide

5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)isophthalamide

5-(N-dhp-acetamido)-2,4,6-triiodo-N,N'-B is-dhp-isophthalami

5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

5-[Acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide

5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide

5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

5-[N-(2,3-Dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)isophthalamide

5-[n-(2,3-Dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)isophthalamidesolution

66108-95-0

A835339

AB0012347

AC-1934

AC1L1GKZ

AKOS015895399

ALBB-028959

AN-14471

API0003012

AS-12699

BC209326

BCBcMAP01_000051

BPBio1_000511

BRN 2406632

BSPBio_000463

C-23546

C19H26I3N3O9

CAS-66108-95-0

CC-29572

CCG-220512

CHEBI:31709

CHEMBL1200455

CS-2811

CTK8G0334

D01817

DB01362

DSSTox_CID_3157

DSSTox_GSID_23157

DSSTox_RID_76895

DTXSID6023157

EBD45459

EC 266-164-2

EINECS 266-164-2

Exypaque

FT-0627276

Histodenz

Histodenz(TM), nonionic density gradient medium

Histodenz™

Histodenz|||Nycodenz

HMS1569H05

HMS2096H05

HMS2235D07

HMS3369O04

HMS3713H05

HY-B0594

I06-0659

I0903

Iohexol (JP17/USP/INN)

Iohexol [USAN:BAN:INN:JAN]

Iohexol [USAN:USP:INN:BAN:JAN]

Iohexol for peak identification, European Pharmacopoeia (EP) Reference Standard

Iohexol injection (JP17)

Iohexol, analytical standard

Iohexol, European Pharmacopoeia (EP) Reference Standard

Iohexol, Pharmaceutical Secondary Standard; Certified Reference Material

Iohexol, United States Pharmacopeia (USP) Reference Standard

Iohexolum

Iohexolum [INN-Latin]

KS-00001F7T

LS-29715

MLS001332585

MLS001332586

MLS002153854

MolPort-003-931-371

N,N'-Bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalamide

n,n'-bis(2,3-dihydroxypropyl)-5-[n-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide

N1,N3-bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalamide

N1,N3-bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide

N1,N3-bis[2,3-bis(oxidanyl)propyl]-5-[2,3-bis(oxidanyl)propyl-ethanoyl-amino]-2,4,6-tris(iodanyl)benzene-1,3-dicarboxamide

NCGC00166000-01

NCGC00166000-02

NCGC00166000-04

NTHXOOBQLCIOLC-UHFFFAOYSA-N

Nycodenz

Omnipaque

Omnipaque (TN)

Omnipaque 180

Omnipaque 210

Omnipaque 240

Omnipaque 70

Prestwick_802

Prestwick0_000512

Prestwick1_000512

Prestwick2_000512

Prestwick3_000512

SC-17734

SCHEMBL26501

SMP1_000152

SMR000857075

SPBio_002384

SR-01000838892

SR-01000838892-2

Tox21_112286

Tox21_112286_1

UNII-4419T9MX03

WIN 39424

WIN-39424

ZX-AN079772

US Patents and Regulatory Information for iohexol

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ge Healthcare	OMNIPAQUE 350	iohexol	SOLUTION;INJECTION, ORAL	018956-004	Dec 26, 1985		RX	Yes	Yes
Ge Healthcare	OMNIPAQUE 300	iohexol	SOLUTION;INJECTION, ORAL, RECTAL	020608-002	Oct 24, 1995		RX	No	No
Ge Healthcare	OMNIPAQUE 9	iohexol	SOLUTION;ORAL	018956-008	Apr 17, 2018		RX	Yes	Yes
Ge Healthcare	OMNIPAQUE 240	iohexol	SOLUTION;INJECTION, ORAL, RECTAL	018956-002	Dec 26, 1985		RX	Yes	Yes
Interpharma Praha As	ORALTAG	iohexol	FOR SOLUTION;ORAL	205383-001	Mar 26, 2015		RX	No	No

Expired US Patents for iohexol

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ge Healthcare	OMNIPAQUE 350	iohexol	SOLUTION;INJECTION, ORAL	018956-004	Dec 26, 1985
Ge Healthcare	OMNIPAQUE 300	iohexol	SOLUTION;INJECTION, ORAL, RECTAL	018956-003	Dec 26, 1985
Ge Healthcare	OMNIPAQUE 350	iohexol	SOLUTION;INJECTION, ORAL	018956-004	Dec 26, 1985
Ge Healthcare	OMNIPAQUE 180	iohexol	SOLUTION;INJECTION, ORAL, RECTAL	018956-001	Dec 26, 1985
Ge Healthcare	OMNIPAQUE 140	iohexol	INJECTABLE;INJECTION	018956-005	Nov 30, 1988